Medicine
Sensorcaine MPF 225 mg/0.15 mg per 30 mL injection
Sensorcaine MPF 225 mg/0.15 mg per 30 mL injection is a prescription medicine containing Bupivacaine and Epinephrine for epidural, retrobulbar use, marketed by Fresenius Kabi, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Solutions should be stored at 20° to 25°C (68° to 77°F). Solutions containing…
Key facts
- Active ingredient (INN)
- Bupivacaine and Epinephrine
- Brand
- Sensorcaine MPF
- Strength
- 225 mg/0.15 mg per 30 mL
- Dosage form
- Injection
- Route
- Epidural, retrobulbar
- Packs
- 25 vials of 30 mL
- Marketing authorisation holder
- Fresenius Kabi
- Manufacturer
- Fresenius Kabi
- Origin register
- US FDA, United States
- Storage
- Solutions should be stored at 20° to 25°C (68° to 77°F). Solutions containing epinephrine should be protected from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 November 2010
- Identifiers
- RxCUI 1012391, 1012396, 1012404 +7DailyMed set ID eb6d8fee-def4-4c96-9972-695e8cea8ea8NDC 63323-460Application NDA018304
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial, single-dose in 1 tray / 30 mL in 1 vial, single-dose | 63323-460-37 | Fresenius Kabi | 19 November 2010 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 3 October 1972 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Bupivacaine and Epinephrine
Clinical summary
Bupivacaine and Epinephrine is a fixed-dose combination of an amide local anesthetic, a catecholamine and an alpha-adrenergic agonist. It is available as injection for perineural, epidural and intracaudal use. MedsAcross supplies Bupivacaine and Epinephrine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Bupivacaine and EpinephrineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Marcaine prescribing information (Hospira) · U.S. National Library of Medicine, DailyMed
Need Sensorcaine MPF 225 mg/0.15 mg per 30 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.